R. Heithecker

Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.

W. Oelkers, Jean Michel Foidart, N. Dombrovicz et al. · The Journal of Clinical Endocrinology & Metabolism · 1995 · 224 citations

Medicine, Endocrinology, Pharmacology +16

Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone

Joakim Huber, Jean‐Michel Foidart, W. Wuttke et al. · The European Journal of Contraception & Reproductive Health Care · 2000 · 146 citations

Medicine, Gynecology, Pharmacology +17

A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel

Jean Michel Foidart, W. Wuttke, G. M. Bouw et al. · The European Journal of Contraception & Reproductive Health Care · 2000 · 122 citations

Medicine, Gynecology, Obstetrics +17

A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism

U Gaspard, André Scheen, Jan Endrikat et al. · Contraception · 2003 · 72 citations · Full text

Medicine, Endocrinology, Pharmacology +13

A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles

U Gaspard, Jan Endrikat, J.P. Desager et al. · Contraception · 2004 · 71 citations

Medicine, Gynecology, Pharmacology +14